127 related articles for article (PubMed ID: 38524109)
41. Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics.
Di Salvo I; Mnzava D; Nicoletti GJ; Senkoro E; Ndege RC; Huang DJ; Makunja NT; Kassiga GI; Kaufmann AM; Weisser M; Kind AB
BMC Health Serv Res; 2023 Mar; 23(1):234. PubMed ID: 36894985
[TBL] [Abstract][Full Text] [Related]
42. The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India.
Anderson JR; Yogeshkumar S; Lu E; Yenokyan G; Thaler K; Mensa M; Chikaraddi S; Lokare L; Gudadinni MR; Antartani R; Donimath K; Patil B; Bidri S; Goudar SS; Derman R; Dalal A;
BJOG; 2023 Nov; 130 Suppl 3(Suppl 3):158-167. PubMed ID: 37932903
[TBL] [Abstract][Full Text] [Related]
43. Visual inspection of cervix with acetic acid: a good alternative to pap smear for cervical cancer screening in resource-limited setting.
Khan M; Sultana SS; Jabeen N; Arain U; Khans S
J Pak Med Assoc; 2015 Feb; 65(2):192-5. PubMed ID: 25842557
[TBL] [Abstract][Full Text] [Related]
44. Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.
Lince-Deroche N; Phiri J; Michelow P; Smith JS; Firnhaber C
PLoS One; 2015; 10(11):e0141969. PubMed ID: 26569487
[TBL] [Abstract][Full Text] [Related]
45. Previous Papanicolaou and Hybrid Capture 2 human papillomavirus testing results of 5699 women with histologically diagnosed cervical intraepithelial neoplasia 2/3.
Wu T; Chen X; Zheng B; Li J; Xie F; Ding X; Zeng Z; Zhao C
J Am Soc Cytopathol; 2019; 8(4):206-211. PubMed ID: 31272603
[TBL] [Abstract][Full Text] [Related]
46. Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study.
Valls J; Baena A; Venegas G; Celis M; González M; Sosa C; Santin JL; Ortega M; Soilán A; Turcios E; Figueroa J; Rodríguez de la Peña M; Figueredo A; Beracochea AV; Pérez N; Martínez-Better J; Lora O; Jiménez JY; Giménez D; Fleider L; Salgado Y; Martínez S; Bellido-Fuentes Y; Flores B; Tatti S; Villagra V; Cruz-Valdez A; Terán C; Sánchez GI; Rodríguez G; Picconi MA; Ferrera A; Mendoza L; Calderón A; Murillo R; Wiesner C; Broutet N; Luciani S; Pérez C; Darragh TM; Jerónimo J; Herrero R; Almonte M;
Lancet Glob Health; 2023 Mar; 11(3):e350-e360. PubMed ID: 36796982
[TBL] [Abstract][Full Text] [Related]
47. Adjunct screening of cervical or vaginal samples using careHPV testing with Pap and aided visual inspection for detecting high-grade cervical intraepithelial neoplasia.
Asthana S; Labani S
Cancer Epidemiol; 2015 Feb; 39(1):104-8. PubMed ID: 25548076
[TBL] [Abstract][Full Text] [Related]
48. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
[TBL] [Abstract][Full Text] [Related]
49. [Analysis of the reported data of national rural cervical cancer screening project from 2012 to 2013, China].
Luo XM; Song L; Wu JL; Liu Y; Di JL; Song B; Zheng RM; Ma L
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Apr; 50(4):346-50. PubMed ID: 27029367
[TBL] [Abstract][Full Text] [Related]
50. Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.
Omenge Orang'o E; Liu T; Christoffersen-Deb A; Itsura P; Oguda J; Washington S; Chumba D; Pisharodi L; Cu-Uvin S; Rositch AF
AIDS; 2017 Jan; 31(2):233-240. PubMed ID: 28002084
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of High-risk Human Papillomavirus Testing for Cervical Cancer Screening in China: A Multicenter, Open-label, Randomized Clinical Trial.
Zhang J; Zhao Y; Dai Y; Dang L; Ma L; Yang C; Li Y; Kong L; Wei L; Zhang S; Liu J; Xi M; Chen L; Duan X; Xiao Q; Abulizi G; Zhang G; Hong Y; Gao X; Zhou Q; Xie X; Li L; Niyazi M; Zhang Z; Tuo J; Ding Y; Si M; Chen F; Song L; Qiao Y; Lang J
JAMA Oncol; 2021 Feb; 7(2):263-270. PubMed ID: 33377903
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of portable colposcopy and human papillomavirus testing for screening of cervical cancer in rural China.
Newman H; Hu J; Li X; He J; Bradford L; Shan S; Wu X; Zhu B; Yang W; Fu B; Zhu B; Gao G
Int J Gynecol Cancer; 2019 Jan; 29(1):23-27. PubMed ID: 30640679
[TBL] [Abstract][Full Text] [Related]
53. [Use of human papilloma virus testing in primary cervical cancer screening in rural Madagascar].
Dumont A; Bessières N; Razafindrafara G; Ravit M; Benbassa A
Rev Epidemiol Sante Publique; 2019 Apr; 67(2):120-125. PubMed ID: 30448093
[TBL] [Abstract][Full Text] [Related]
54. Role of various screening techniques in detecting preinvasive lesions of the cervix among symptomatic women and women having unhealthy cervix.
Nayak PK; Mitra S; Agrawal S; Hussain N; Thakur P; Mishra B
J Cancer Res Ther; 2021; 17(1):180-185. PubMed ID: 33723152
[TBL] [Abstract][Full Text] [Related]
55. Clinical determinants of a positive visual inspection after treatment with acetic acid for cervical cancer screening.
Castle PE; Qiao YL; Zhao FH; Chen W; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Jeronimo J
BJOG; 2014 May; 121(6):739-46. PubMed ID: 24575872
[TBL] [Abstract][Full Text] [Related]
56. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy.
Mustafa RA; Santesso N; Khatib R; Mustafa AA; Wiercioch W; Kehar R; Gandhi S; Chen Y; Cheung A; Hopkins J; Ma B; Lloyd N; Wu D; Broutet N; Schünemann HJ
Int J Gynaecol Obstet; 2016 Mar; 132(3):259-65. PubMed ID: 26851054
[TBL] [Abstract][Full Text] [Related]
57. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
58. The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Silver MI; Schiffman M; Fetterman B; Poitras NE; Gage JC; Wentzensen N; Lorey T; Kinney WK; Castle PE
Cancer; 2016 Dec; 122(23):3682-3686. PubMed ID: 27657992
[TBL] [Abstract][Full Text] [Related]
59. CareHPV cervical cancer screening demonstration in a rural population of north India.
Labani S; Asthana S; Sodhani P; Gupta S; Bhambhani S; Pooja B; Lim J; Jeronimo J
Eur J Obstet Gynecol Reprod Biol; 2014 May; 176():75-9. PubMed ID: 24685404
[TBL] [Abstract][Full Text] [Related]
60. Visual inspection of the cervix with acetic acid for cervical intraepithelial lesions.
Goel A; Gandhi G; Batra S; Bhambhani S; Zutshi V; Sachdeva P
Int J Gynaecol Obstet; 2005 Jan; 88(1):25-30. PubMed ID: 15617701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
